22 Jul 2014
Medullary thyroid carcinomas (MTC) account for 2–10% of all thyroid carcinomas. Of late, small medullary thyroid carcinomas (smallMTCs: ≤1.5 cm) are diagnosed more frequently, possibly because of routine calcitonin measurement in nodular disease. However, their clinical significance and natural history are not clear.
In order to evaluate the clinical significance of smallMTCs (≤1.5 cm), Saltiki et al. examined the clinical and biochemical parameters at diagnosis and during follow-up in a cohort of MTC patients focusing on tumour size in a retrospective study.
They found that tumour size is of clinical importance for the progression of disease only in patients with MTCs >1 cm. This study also confirmed that post-operative calcitonin is a more important predictor than size for disease progression.
Read full article at Saltiki et al. (2014) European Journal of Endocrinology 171 117–126. DOI: 10.1530/EJE-14-0076
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024